Accelerated Approvals Could Raise Risks for Patients
Updated: 2011-11-08 09:20:53
FDA approved 35 innovative drugs in fiscal 2011, including treatments for hepatitis C, prostate cancer, Hodgkin’s lymphoma, and lupus. This number of approvals is among the highest in the past 10 years, and it reflects the agency’s efforts to hasten patients’ access to new drugs. In the past two years, ...

A just-released special supplement to the journal Women’s Health Issues provides in-depth information about gender-specific health considerations of U.S. women and girls in the HIV/AIDS epidemic and recommendations for national strategic programmatic improvements to meet their needs. The supplement grew out of a June 2010 forum, Bringing Gender Home: Implementing Gender-Responsive HIV/AIDS Programming for U.S....
Training primary care providers on HIV/AIDS-related prevention, care and treatment is key to achieving the National HIV/AIDS Strategy’s (NHAS) goal of increasing access to care and optimizing health outcomes for people living with HIV/AIDS. The Health Resources and Services Administration (HRSA) is working collaboratively across our Bureaus to pursue the Strategy’s goals and has made...
This week, Dr. Howard Koh, our Assistant Secretary for Health, unveiled critical health priorities for the nation known as “Leading Health Indicators” (LHIs). I am very pleased to point out that these important national indicators include an HIV-related measure. Announced at the 138th Annual Meeting of the American Public Health Association, the LHIs are a...
More than 200 in-person and over 180 webcast attendees participated in a recent symposium held in New York City at the U.S. Department of Health and Human Services (HHS) Region II office. The meeting was convened by the Office of the Assistant Secretary for Health (OASH), Office of the Regional Health Administrator, Regional Resource Network...
, , : Science Speaks : HIV TB News A project of the Center for Global Health Policy Search Search : for Go Home About Liveblog Archives you’re reading . Global Health Financing continued global health development , TB in Texas and abroad , and more By Meredith Mazzotta November 2, 2011 Post a comment The following What We’re Reading” collection is a compilation of recent articles making headlines in HIV and TB . news Bill Gates’ Plan to Assist the World’s Poor In this Washington Post op-ed , Bill Gates gave a preview to his report to the leaders of the world’s 20 major economies at Thursday’s G-20 Summit in France . According to the piece , his report on innovative ways to finance global development programs during the worldwide economic downturn focuses on three key ideas : aid is most
Recently, I had the pleasure of participating in the National Viral Hepatitis Technical Assistance Meeting where there was significant focus on realizing the potential of the Viral Hepatitis Action Plan. Organized by the National Alliance for State and Territorial AIDS Directors and the National Viral Hepatitis Roundtable , the meeting brought together Adult Viral Hepatitis...
The AIDS Foundation of Chicago is grateful to Mayor Rahm Emanuel, whose recent budget proposal did not cut vital city funding for HIV prevention programs, services, and agencies, in spite of the bleak, slow-to-recover economy.
The AIDS Foundation of Chicago (AFC) recently eceived from he hicago Department of Public Health (CDPH) a full list of how the city spends its HIV prevention dollars. The ocument reveals that 88% of CDPH cityread more
The U.S. Conference on AIDS (USCA) 2011 is less than two weeks away. As Paul Kawata, Executive Director of the National Minority AIDS Council noted in his recent blog post, this year’s conference is pivotal. With the conference theme, “Make Change Real,” over 3,000 federal, national, and community-level HIV partners will gather in Chicago to...
Infectious Diseases experts give progress updates on treatment as prevention, prevention of mother-to-child transmission, and medical male circumcision(Read more...)
College students, people living with AIDS, and community members held a “pool party” outside of Merck’s laboratories in Boston Friday, to speak out about the company’s hesitation to join the Medicines Patent Pool (MPP) – a two-year-old organization that works with drug companies to create licenses that allow generic drug companies to produce their patented [...](Read more...)
BOSTON -- The effects of the hepatitis B vaccine appeared to last long-term in HIV-infected patients even if they have high CD4-positive cell counts, researchers said here.